Physician
General Surgery
Dr. Itzhak Avital, MD
|
|
Give Review
Dr. Itzhak Avital practices General Surgery. He graduated from NYU School of Medicine. He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow". Itzhak Avital, MD is also a published doctor. He has 32 publication published. The most recent publication is: Pathway and network approaches for identification of cancer signature markers from omics data. Itzhak Avital accepts Medicare payments and is registered with Medicare.gov.
Publications
- Differential Impact of Tumor-infiltrating Immune Cells on Basal and Luminal Cells: Implications for Tumor Invasion and Metastasis.
- Value of Primary Tumor Gene Signatures in Colon Cancer When National Quality Standards are Adhered to: Preliminary Results of an International Prospective Multicenter ...
- Duodenal ischemia and upper GI bleeding are dose-limiting toxicities of 24-h continuous intra-arterial pancreatic perfusion of gemcitabine following vascular isolation...
- Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric orig...
- Time-dependent Estimates of Recurrence and Survival in Colon Cancer: Clinical Decision Support System Tool Development for Adjuvant Therapy and Oncological Outcome Ass...
- Safety of major abdominal surgical procedures in patients with hyperimmunoglobulinemia E (Job's syndrome): a changing paradigm?
- Surgery for Li Fraumeni Syndrome: Pushing the Limits of Surgical Oncology.
- Evidence-based Guidelines for Precision Risk Stratification-Based Screening (PRSBS) for Colorectal Cancer: Lessons learned from the US Armed Forces: Consensus and Futu...
- Serum-based DNA methylation biomarkers in colorectal cancer: potential for screening and early detection.
- Significance of infectious agents in colorectal cancer development.
- Colorectal cancer biomarkers and the potential role of cancer stem cells.
- Special issue on precision risk stratification-based screening in colorectal cancer.
- Colorectal cancer stem cells as biomarkers: Where it all starts?
- Multi-Parametric MRI-Directed Focal Salvage Permanent Interstitial Brachytherapy for Locally Recurrent Adenocarcinoma of the Prostate: A Novel Approach.
- Tumor-infiltrating immune cells promoting tumor invasion and metastasis: existing theories.
- Label-retaining liver cancer cells are relatively resistant to sorafenib.
- A novel nomogram for peritoneal mesothelioma predicts survival.
- Technical Effects of Adding 1 % Lidocaine to Technetium Sulfur Colloid for Sentinel Lymphatic Mapping in Early Breast Cancer: Analysis of Data from a Double-blind Rand...
- Clinical decision support and individualized prediction of survival in colon cancer: bayesian belief network model.
- Randomized clinical trials for colorectal cancer peritoneal surface malignancy.
- Special issue on current challenges and future directions in monitoring responses after treatment of primary cancer.
- Current Approaches, Challenges and Future Directions for Monitoring Treatment Response in Prostate Cancer.
- Current Approaches and Challenges for Monitoring Treatment Response in Colon and Rectal Cancer.
- Future Directions for Monitoring Treatment Response in Colorectal Cancer.
- Isolation of stem cells using spheroids from fresh surgical specimen: an analytic mini-review.
- Pathway and network approaches for identification of cancer signature markers from omics data.
- Future Directions for the Early Detection of Recurrent Breast Cancer.
- Current Approaches and Challenges in Early Detection of Breast Cancer Recurrence.
- Early Detection of Colorectal Cancer Recurrence in Patients Undergoing Surgery with Curative Intent: Current Status and Challenges.
- Special issue on current challenges and future directions in monitoring recurrence after treatment of primary cancer.
- Wnt and the cancer niche: paracrine interactions with gastrointestinal cancer cells undergoing asymmetric cell division.
Doctors Specialties
- General Surgery
- Surgery
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow
Education
-
Cedars-Sinai Medical Center -
North Shore-Long Island Jewish Health System -
NYU School of Medicine
Drug Facts
| NPI NUMBER | 1245512565 | |
| NPPES Provider LastName | AVITAL | |
| NPPES Provider FirstName | ITZHAK | |
| NPPES Provider ZIPCode | 232261934 | |
| NPPES Provider State | VA | |
| Specialty Description | General Surgery | |
| Total Claim Count | 15.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1245512565 |
| Last Name Of The Provider | AVITAL |
| First Name Of The Provider | ITZHAK |
| View All |
Similar Doctors
|
Dr. Gregory L. Schroder, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. James J. Stone, MD |
|
|
Dr. David T. Farr, MD |
|
|
Dr. Dan W. Parrish, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Victoria J. Whitlow, MD |